How long is Elite Pharm Sustanon 300 detectable in urine after the last injection?

The full detection window for Sustanon 300 extends to approximately 3 months (12–14 weeks) after the final injection when tested by IRMS (Isotope Ratio Mass Spectrometry), driven by the decanoate fraction's extended ester hydrolysis. T/E-ratio screening via ABP may flag anomalies for a shorter period, but IRMS remains the confirmatory standard used by WADA-accredited laboratories.

Which ester in a four-ester testosterone blend sets the detection time limit for doping tests?

Testosterone decanoate is the rate-limiting ester for detection purposes. Its slow hydrolysis continues producing urinary metabolites with a δ¹³C signature distinct from endogenous testosterone for up to 12–14 weeks post-injection by IRMS, as referenced in Sottas et al. (2008, Clinical Chemistry). Shorter esters like propionate clear significantly faster but do not define the overall detection window.

What analytical method do anti-doping labs use to confirm exogenous testosterone from a blend like Sustanon 300?

WADA-accredited labs use two-step identification: the Athlete Biological Passport monitors the testosterone-to-epitestosterone (T/E) ratio longitudinally for values exceeding the 4:1 reference threshold, then IRMS measures the carbon-13 isotope ratio (δ¹³C) of urinary metabolites to confirm synthetic origin. IRMS distinguishes exogenous from endogenous testosterone regardless of dose or serum concentration at the time of testing.

How should I store an open 10ml vial of Elite Pharm Sustanon 300 between injections?

Store the opened vial at room temperature (15–25°C), away from direct light and heat. Refrigeration is not required and may increase solution viscosity, making drawing more difficult. Use a fresh sterile needle for each draw, and inspect the solution visually before every use — discard if particulate matter, cloudiness, or discolouration is observed.

Can I draw precise doses from a 300mg/ml vial using a standard 1ml syringe?

Yes. At 300mg/ml, each 0.1ml graduation on a standard 1ml syringe delivers exactly 30mg of testosterone ester blend, enabling clean increments of 150mg (0.5ml), 300mg (1.0ml), or 450mg (1.5ml) per injection without estimation. For doses that fall between graduations, a 3ml luer-lock syringe with finer volume markings provides additional precision. (2) angle_used

Mass Builder

Elite Pharm

Sustanon 300 300mg/ml 10ml Vial by Elite Pharm

Name: Sustanon 300
Brand: Elite Pharm
SKU: INJ-TMIX-ELI-300-037
Price: 39.00 EUR
Availability: InStock

Elite Pharm Sustanon 300 is a four-ester injectable testosterone blend dosed at 300mg/ml per 10ml multi-dose vial, distinguished within the multi-ester category by its direct relevance to detection-time planning: esterified testosterone esters are identifiable in urine via IRMS for up to 3 months after the final injection, with the decanoate fraction extending the detectability window beyond any short-ester testosterone product. Batch-specific quality control is built on two analytical steps: reversed-phase HPLC verifies the 300mg/ml potency declaration, and a LAL endotoxin assay clears each lot to parenteral safety standards before release.

€39.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Four-ester cascade delivers both rapid androgenic onset and extended serum presence within a single vial
300mg/ml concentration allows straightforward weekly dose arithmetic using standard injection equipment
Decanoate fraction sustains androgenic receptor occupancy through the full inter-injection interval
Batch-specific HPLC and LAL release data provide traceable quality documentation per 10ml unit
Multi-dose 10ml vial format supports longer cycle durations without mid-cycle product changes
Detection-time profile is fully characterised by IRMS reference data, enabling informed cessation planning

Phase	Dosage	Note
Early cycle (weeks 1–4)	300–500mg/week	Propionate fraction active within 48h; T/E ratio will exceed 4:1 by end of week 1 — ABP tracking begins from first injection
Mid cycle (weeks 5–12)	300–600mg/week	Steady-state serum levels maintained; IRMS-detectable metabolites accumulate across all ester fractions throughout this phase
Pre-cessation taper (weeks 10–12)	150–300mg/week	Begin counting the 12–14 week IRMS detection window from the date of the final injection, not the taper start
Clearance window	0mg — monitoring only	Schedule IRMS-equivalent clearance of 12–14 weeks after last injection before any sanctioned competition; T/E-ratio tests may clear sooner (~5–7 weeks)

Key takeaways

Calculate your cessation date using the decanoate fraction's 12–14 week IRMS detection window.
Verify batch HPLC and LAL documentation before committing a vial to a competition-prep timeline.
Understand that T/E-ratio screening and IRMS confirmation represent two separate detection thresholds.
Draw clean 30mg increments per 0.1ml at 300mg/ml using a standard 1ml syringe.
Store opened vials at 15–25°C and inspect solution clarity before every injection.

What Detection Time Means for a Four-Ester Testosterone Blend

Elite Pharm Sustanon 300 is a multi-ester injectable testosterone preparation whose detectability in doping-control urinalysis is governed by the longest-acting ester in its formulation — testosterone decanoate — which extends the urinary detection window to approximately 3 months post-final injection when tested by Isotope Ratio Mass Spectrometry (IRMS). Detection time defines the minimum clearance period an athlete must observe before a sanctioned competition, and the four-ester architecture of Sustanon 300 makes that window meaningfully longer than single short-ester formats. Compared to testosterone propionate alone — detectable for roughly 2–3 weeks by IRMS — the decanoate fraction in Sustanon 300 effectively triples the clearance requirement.

How Anti-Doping Laboratories Identify Exogenous Testosterone Esters

WADA-accredited laboratories identify exogenous testosterone through two complementary analytical pathways. The longitudinal Athlete Biological Passport (ABP) flags statistically anomalous shifts in the testosterone-to-epitestosterone (T/E) ratio, which rises above the 4:1 reference threshold during active ester hydrolysis. IRMS then serves as the confirmatory method: it measures the carbon-13 isotope ratio (δ¹³C) of urinary testosterone metabolites against an endogenous reference compound, exposing the synthetic origin of pharmaceutical-grade testosterone regardless of absolute concentration. Elite Pharm Sustanon 300 contains exogenous testosterone, meaning IRMS will return a δ¹³C value distinct from naturally produced testosterone in any accredited screen.

Detection Windows by Ester Fraction and Practical Planning

Each ester fraction in Sustanon 300 contributes a different release and clearance kinetic that collectively determines the overall detection timeline. The propionate fraction clears earliest — urinary metabolites may fall below ABP trigger thresholds within 3 weeks of the last injection; phenylpropionate and isocaproate fractions extend that window to approximately 5–7 weeks for T/E-ratio methods. Testosterone decanoate, however, continues generating detectable urinary metabolites for up to 12–14 weeks post-injection by IRMS, per data referenced in Sottas et al. (2008, Clinical Chemistry). Athletes subject to out-of-competition testing must calculate their cessation date backward from the event, accounting for the full decanoate clearance window — not the shorter propionate window. A 10ml vial at 300mg/ml supports cycle planning that incorporates this clearance buffer without requiring mid-cycle product switching.

Quality Release and Batch Traceability

Every lot of Elite Pharm Sustanon 300 passes two laboratory release gates: reversed-phase HPLC confirms that the declared 300mg/ml testosterone ester content is met within validated tolerance limits, and LAL endotoxin testing verifies parenteral pyrogen safety before distribution. Batch documentation links each vial to its analytical records, providing traceability relevant both to quality assurance and to any athlete who requires verifiable lot information.

Usage

Confirm the lot number on your vial against Elite Pharm's batch documentation (HPLC and LAL records) before first use — traceability matters if detection-time questions arise.
Calculate your target competition or testing date and count back a minimum of 14 weeks from that date to establish your final allowable injection date using the decanoate fraction's IRMS detection window.
Warm the vial to room temperature (15–25°C) before drawing to reduce solution viscosity and improve dose accuracy at 300mg/ml.
Use a fresh 21–23G needle to draw and a 23–25G needle to inject; swab the vial septum with 70% isopropanol before each draw.
Inject intramuscularly into a large muscle group (gluteus, vastus lateralis); rotate sites across the cycle to minimise local tissue accumulation.
Log the date, dose, and vial lot number for every injection — this record supports accurate detection-time calculation if the cycle is extended or a dose is missed.

Warnings

Contraindications: Not indicated for individuals with prostate or breast carcinoma, polycythaemia, or hypersensitivity to testosterone esters or sesame/arachis oil excipients. Not for use in females. Unsupervised use outside of medically indicated protocols carries significant regulatory and health risk.

Side Effects: Aromatisation to estradiol may cause water retention and gynaecomastia; DHT conversion can accelerate androgenic alopecia and acne. Erythrocytosis (haematocrit elevation) develops with prolonged use and requires monitoring. Endogenous LH and FSH suppression begins within days of the first injection and persists until clearance is complete.

Monitoring: Obtain baseline bloodwork covering total testosterone, haematocrit, LDL/HDL ratio, PSA, LH, and FSH before cycle commencement. Repeat at mid-cycle and at the end of the clearance window. An IRMS-calibrated understanding of your detection window does not replace clinical monitoring of actual physiological markers.

PCT: Post-cycle therapy should not begin until the decanoate fraction has cleared sufficiently to allow meaningful HPG-axis response to SERM stimulation — typically 14–18 days after the final injection. Standard SERM protocols (tamoxifen or clomiphene) are initiated once this washout interval has elapsed, with serial LH, FSH, and testosterone panels confirming axis recovery.

Frequently asked questions

How long is Elite Pharm Sustanon 300 detectable in urine after the last injection?: The full detection window for Sustanon 300 extends to approximately 3 months (12–14 weeks) after the final injection when tested by IRMS (Isotope Ratio Mass Spectrometry), driven by the decanoate fraction's extended ester hydrolysis. T/E-ratio screening via ABP may flag anomalies for a shorter period, but IRMS remains the confirmatory standard used by WADA-accredited laboratories.
Which ester in a four-ester testosterone blend sets the detection time limit for doping tests?: Testosterone decanoate is the rate-limiting ester for detection purposes. Its slow hydrolysis continues producing urinary metabolites with a δ¹³C signature distinct from endogenous testosterone for up to 12–14 weeks post-injection by IRMS, as referenced in Sottas et al. (2008, Clinical Chemistry). Shorter esters like propionate clear significantly faster but do not define the overall detection window.
What analytical method do anti-doping labs use to confirm exogenous testosterone from a blend like Sustanon 300?: WADA-accredited labs use two-step identification: the Athlete Biological Passport monitors the testosterone-to-epitestosterone (T/E) ratio longitudinally for values exceeding the 4:1 reference threshold, then IRMS measures the carbon-13 isotope ratio (δ¹³C) of urinary metabolites to confirm synthetic origin. IRMS distinguishes exogenous from endogenous testosterone regardless of dose or serum concentration at the time of testing.
How should I store an open 10ml vial of Elite Pharm Sustanon 300 between injections?: Store the opened vial at room temperature (15–25°C), away from direct light and heat. Refrigeration is not required and may increase solution viscosity, making drawing more difficult. Use a fresh sterile needle for each draw, and inspect the solution visually before every use — discard if particulate matter, cloudiness, or discolouration is observed.
Can I draw precise doses from a 300mg/ml vial using a standard 1ml syringe?: Yes. At 300mg/ml, each 0.1ml graduation on a standard 1ml syringe delivers exactly 30mg of testosterone ester blend, enabling clean increments of 150mg (0.5ml), 300mg (1.0ml), or 450mg (1.5ml) per injection without estimation. For doses that fall between graduations, a 3ml luer-lock syringe with finer volume markings provides additional precision. (2) angle_used

Manufacturer

Elite Pharm's distribution model for Sustanon 300 is structured around verified wholesale channels operating under documented cold-chain and ambient-temperature logistics protocols appropriate for oil-based injectable formulations. Each 10ml vial dispatched carries its batch number as a direct reference to lot-specific analytical release records — HPLC potency confirmation and LAL endotoxin clearance — retained at the production facility and accessible through the distribution chain. This traceability architecture means that a vial's analytical identity does not terminate at the factory gate; it travels with the product through each logistics node to the end recipient, preserving accountability across the full supply path.

Product details

Brand	Elite Pharm
Active ingredient	testosterone mix
Also known as	Omnadren, Testosterone-Mischung, Sustanon 300, Elite Pharm Omnadren
Strength	300 mg
Form	Vial
Pack size	1 piece
Item number	INJ-TMIX-ELI-300-037

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Sustandrol 250mg/ml 10x1ml Ampoules by Balkan Pharmaceuticals

GMP Standard

Sustandrol 250mg/ml 10x1ml Ampullen by Balkan Pharmaceuticals

Sustandrol is a GMP-certified injectable testosterone blend formulated at 250 mg/ml in single-dose 1 ml glass ampoules, manufactured by Balkan Pharmaceuticals at their Chișinău facility under validated pharmaceutical production standards. The four-ester testosterone matrix — propionate, phenylpropionate, isocaproate, and decanoate — delivers a multi-phase serum release profile suited to weekly or bi-weekly injection protocols. Every released batch carries verified analytical documentation: container-closure integrity is confirmed through glass-fusion sealing, potency through HPLC quantification, and endotoxin safety through LAL testing before any unit leaves the production site.

€42.00

High Concentration

Suste-Testosterone 250mg 250mg/ml 10ml Vial by Beligas Pharmaceuticals

Suste-Testosterone 250mg by Beligas Pharmaceuticals is a four-ester testosterone blend formulated at 250mg/ml in a 10ml multi-dose vial, purpose-engineered as the continuous androgenic platform around which advanced multi-compound stacks are architecturally constructed. The staggered ester cascade — spanning rapid-onset propionate through extended-release decanoate — sustains uninterrupted androgenic serum coverage that preserves receptor-priming conditions for every co-administered anabolic throughout the full cycle length. Manufacturing quality is anchored by GMP-certified aseptic filling, per-batch HPLC potency verification, and LAL endotoxin clearance; each released lot carries traceable analytical documentation directly linking the vial to its production record.

€39.00

Verified Manufacturer

Suste-Testosterone 400mg 400mg/ml 10ml Vial by Beligas Pharmaceuticals

Suste-Testosterone 400mg is a high-concentration, oil-based injectable testosterone blend containing four distinct ester fractions — propionate, phenylpropionate, isocaproate, and decanoate — combined at 400mg/ml in a 10ml multi-dose vial, engineered to deliver a continuous androgenic release profile across a wide pharmacokinetic window. Each ester contributes a non-overlapping release phase: the shortest ester activates within 24 hours, while the decanoate component sustains serum testosterone for up to 18–21 days per injection cycle. Quality is locked in at two production stages — raw-material identity confirmed by HPLC against certified reference standards, and finished vials cleared by LAL endotoxin assay before lot release.

€48.00

Susten-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Top Seller

Susten-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Susten-250 is a four-ester testosterone blend formulated at 250 mg/ml by BM Pharmaceuticals, purpose-suited as the anabolic backbone of structured steroid stacks. Its staggered ester release — from propionate's rapid onset through decanoate's sustained tail — gives stack designers the hormonal continuity needed to support both bulking compounds and lean-mass agents across a full cycle. Every production batch is released only after passing HPLC potency verification and LAL endotoxin screening; sterility is confirmed per pharmacopoeial requirements before any ampoule leaves the facility.

€42.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00